Logo image of TEAM

ATLASSIAN CORP-CL A (TEAM) Stock Fundamental Analysis

USA - NASDAQ:TEAM - US0494681010 - Common Stock

168.975 USD
-0.66 (-0.39%)
Last: 9/19/2025, 10:35:08 AM
Fundamental Rating

4

Taking everything into account, TEAM scores 4 out of 10 in our fundamental rating. TEAM was compared to 280 industry peers in the Software industry. The financial health of TEAM is average, but there are quite some concerns on its profitability. TEAM is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

TEAM had positive earnings in the past year.
TEAM had a positive operating cash flow in the past year.
TEAM had negative earnings in each of the past 5 years.
In the past 5 years TEAM always reported a positive cash flow from operatings.
TEAM Yearly Net Income VS EBIT VS OCF VS FCFTEAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

TEAM has a Return On Assets (-4.25%) which is in line with its industry peers.
The Return On Equity of TEAM (-19.08%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.25%
ROE -19.08%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TEAM Yearly ROA, ROE, ROICTEAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

With an excellent Gross Margin value of 82.84%, TEAM belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
In the last couple of years the Gross Margin of TEAM has remained more or less at the same level.
TEAM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.12%
TEAM Yearly Profit, Operating, Gross MarginsTEAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

5

2. Health

2.1 Basic Checks

TEAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
TEAM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TEAM Yearly Shares OutstandingTEAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
TEAM Yearly Total Debt VS Total AssetsTEAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

TEAM has an Altman-Z score of 5.64. This indicates that TEAM is financially healthy and has little risk of bankruptcy at the moment.
TEAM has a better Altman-Z score (5.64) than 70.71% of its industry peers.
The Debt to FCF ratio of TEAM is 0.70, which is an excellent value as it means it would take TEAM, only 0.70 years of fcf income to pay off all of its debts.
TEAM has a better Debt to FCF ratio (0.70) than 76.79% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that TEAM is somewhat dependend on debt financing.
TEAM's Debt to Equity ratio of 0.73 is on the low side compared to the rest of the industry. TEAM is outperformed by 70.71% of its industry peers.
Even though the debt/equity ratio score it not favorable for TEAM, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 0.7
Altman-Z 5.64
ROIC/WACCN/A
WACC11.21%
TEAM Yearly LT Debt VS Equity VS FCFTEAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

TEAM has a Current Ratio of 1.22. This is a normal value and indicates that TEAM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.22, TEAM is doing worse than 61.43% of the companies in the same industry.
TEAM has a Quick Ratio of 1.22. This is a normal value and indicates that TEAM is financially healthy and should not expect problems in meeting its short term obligations.
TEAM has a worse Quick ratio (1.22) than 61.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
TEAM Yearly Current Assets VS Current LiabilitesTEAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.60% over the past year.
TEAM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.19% yearly.
TEAM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.66%.
Measured over the past years, TEAM shows a very strong growth in Revenue. The Revenue has been growing by 26.43% on average per year.
EPS 1Y (TTM)25.6%
EPS 3Y29.36%
EPS 5Y26.19%
EPS Q2Q%48.48%
Revenue 1Y (TTM)19.66%
Revenue growth 3Y23%
Revenue growth 5Y26.43%
Sales Q2Q%22.34%

3.2 Future

Based on estimates for the next years, TEAM will show a very strong growth in Earnings Per Share. The EPS will grow by 21.58% on average per year.
Based on estimates for the next years, TEAM will show a quite strong growth in Revenue. The Revenue will grow by 17.41% on average per year.
EPS Next Y18.14%
EPS Next 2Y20.64%
EPS Next 3Y21.51%
EPS Next 5Y21.58%
Revenue Next Year18.95%
Revenue Next 2Y18.94%
Revenue Next 3Y18.94%
Revenue Next 5Y17.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TEAM Yearly Revenue VS EstimatesTEAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
TEAM Yearly EPS VS EstimatesTEAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.92 indicates a quite expensive valuation of TEAM.
TEAM's Price/Earnings is on the same level as the industry average.
TEAM is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 38.87, TEAM can be considered very expensive at the moment.
TEAM's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.88. TEAM is valued rather expensively when compared to this.
Industry RankSector Rank
PE 45.92
Fwd PE 38.87
TEAM Price Earnings VS Forward Price EarningsTEAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TEAM is valued a bit cheaper than 72.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.31
EV/EBITDA N/A
TEAM Per share dataTEAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as TEAM's earnings are expected to grow with 21.51% in the coming years.
PEG (NY)2.53
PEG (5Y)1.75
EPS Next 2Y20.64%
EPS Next 3Y21.51%

0

5. Dividend

5.1 Amount

No dividends for TEAM!.
Industry RankSector Rank
Dividend Yield N/A

ATLASSIAN CORP-CL A

NASDAQ:TEAM (9/19/2025, 10:35:08 AM)

168.975

-0.66 (-0.39%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-31 2025-10-31/amc
Inst Owners96.1%
Inst Owner Change0.05%
Ins Owners0.33%
Ins Owner Change-4.2%
Market Cap44.33B
Analysts81.11
Price Target258.43 (52.94%)
Short Float %3.44%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.55%
Min EPS beat(2)2.87%
Max EPS beat(2)12.23%
EPS beat(4)4
Avg EPS beat(4)14.16%
Min EPS beat(4)2.87%
Max EPS beat(4)24.37%
EPS beat(8)8
Avg EPS beat(8)17.16%
EPS beat(12)11
Avg EPS beat(12)20.7%
EPS beat(16)14
Avg EPS beat(16)20.68%
Revenue beat(2)1
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)0.1%
Revenue beat(4)3
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-1.4%
Max Revenue beat(4)1.7%
Revenue beat(8)5
Avg Revenue beat(8)0.8%
Revenue beat(12)7
Avg Revenue beat(12)0.45%
Revenue beat(16)11
Avg Revenue beat(16)1.29%
PT rev (1m)-7.71%
PT rev (3m)-9.51%
EPS NQ rev (1m)-3.3%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)0.79%
EPS NY rev (3m)-0.64%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)-1.38%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 45.92
Fwd PE 38.87
P/S 8.5
P/FCF 31.31
P/OCF 30.35
P/B 32.94
P/tB N/A
EV/EBITDA N/A
EPS(TTM)3.68
EY2.18%
EPS(NY)4.35
Fwd EY2.57%
FCF(TTM)5.4
FCFY3.19%
OCF(TTM)5.57
OCFY3.29%
SpS19.88
BVpS5.13
TBVpS-0.78
PEG (NY)2.53
PEG (5Y)1.75
Profitability
Industry RankSector Rank
ROA -4.25%
ROE -19.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.84%
FCFM 27.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.12%
F-Score8
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 0.7
Debt/EBITDA N/A
Cap/Depr 48.55%
Cap/Sales 0.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 5.64
F-Score8
WACC11.21%
ROIC/WACCN/A
Cap/Depr(3y)44.32%
Cap/Depr(5y)67.34%
Cap/Sales(3y)0.78%
Cap/Sales(5y)1.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.6%
EPS 3Y29.36%
EPS 5Y26.19%
EPS Q2Q%48.48%
EPS Next Y18.14%
EPS Next 2Y20.64%
EPS Next 3Y21.51%
EPS Next 5Y21.58%
Revenue 1Y (TTM)19.66%
Revenue growth 3Y23%
Revenue growth 5Y26.43%
Sales Q2Q%22.34%
Revenue Next Year18.95%
Revenue Next 2Y18.94%
Revenue Next 3Y18.94%
Revenue Next 5Y17.41%
EBIT growth 1Y-11.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.39%
EBIT Next 3Y24.98%
EBIT Next 5Y22.29%
FCF growth 1Y0.04%
FCF growth 3Y23.78%
FCF growth 5Y21.32%
OCF growth 1Y0.84%
OCF growth 3Y21.16%
OCF growth 5Y20.53%